Literature DB >> 22421219

BMP signaling is responsible for serum-induced Id2 expression.

Hisanori Kurooka1, Takeshi Nakahiro, Kentaro Mori, Kazuo Sano, Yoshifumi Yokota.   

Abstract

Ids function as negative regulators of basic helix-loop-helix transcription factors and their expression is rapidly induced by serum stimulation in various cell types. In this study, we investigated the molecular basis of serum-induced expression of the mouse Id2 gene in NIH3T3 cells. A small-molecule inhibitor of bone morphogenetic protein (BMP) type I receptor kinases blocked the serum induction of Id2 mRNA. The chemical compound and several inhibitory proteins specific for BMP signaling suppressed the serum-induced activation of the luciferase construct with the mouse Id2 4.6-kb promoter region. Importantly, serum stimulation evoked rapid phosphorylation of Smad1/5/8 and significant activation of the reporter plasmid containing the recently identified BMP-responsive element (BRE) of the mouse Id2. Mutation analysis demonstrated that the binding sites for Smad proteins in the Id2 BRE were critical for serum response of the 4.6-kb whole construct. Gel shift and chromatin immunoprecipitation (ChIP) assays confirmed the serum-inducible binding of Smad1/5/8 and Smad4 to the Id2 BRE in vitro and in vivo. Finally, a knockdown experiment revealed the functional importance of Smad1 in the serum induction of Id2 expression. Thus, we concluded that BMP signaling is primarily responsible for the serum-induced Id2 expression. Our results also suggest that some of the cellular effects caused by serum are mediated through BMP signaling.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421219     DOI: 10.1016/j.bbrc.2012.02.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Authors:  Jenna H Newman; David J Augeri; Rachel NeMoyer; Jyoti Malhotra; Elaine Langenfeld; Charles B Chesson; Natalie S Dobias; Michael J Lee; Saeed Tarabichi; Sachin R Jhawar; Praveen K Bommareddy; Sh'Rae Marshall; Evita T Sadimin; John E Kerrigan; Michael Goedken; Christine Minerowicz; Salma K Jabbour; Shengguo Li; Mary O Carayannopolous; Andrew Zloza; John Langenfeld
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

2.  E proteins sharpen neurogenesis by modulating proneural bHLH transcription factors' activity in an E-box-dependent manner.

Authors:  Gwenvael Le Dréau; René Escalona; Raquel Fueyo; Antonio Herrera; Juan D Martínez; Susana Usieto; Anghara Menendez; Sebastian Pons; Marian A Martinez-Balbas; Elisa Marti
Journal:  Elife       Date:  2018-08-10       Impact factor: 8.140

3.  Serum regulation of Id1 expression by a BMP pathway and BMP responsive element.

Authors:  Thera C Lewis; Ron Prywes
Journal:  Biochim Biophys Acta       Date:  2013-08-13

4.  Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.

Authors:  S Tsukamoto; T Mizuta; M Fujimoto; S Ohte; K Osawa; A Miyamoto; K Yoneyama; E Murata; A Machiya; E Jimi; S Kokabu; T Katagiri
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

5.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Authors:  Pawel Buczkowicz; Christine Hoeman; Patricia Rakopoulos; Sanja Pajovic; Louis Letourneau; Misko Dzamba; Andrew Morrison; Peter Lewis; Eric Bouffet; Ute Bartels; Jennifer Zuccaro; Sameer Agnihotri; Scott Ryall; Mark Barszczyk; Yevgen Chornenkyy; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Francisco Cordero; Pedro Castelo-Branco; Joshua Mangerel; Uri Tabori; King Ching Ho; Annie Huang; Kathryn R Taylor; Alan Mackay; Anne E Bendel; Javad Nazarian; Jason R Fangusaro; Matthias A Karajannis; David Zagzag; Nicholas K Foreman; Andrew Donson; Julia V Hegert; Amy Smith; Jennifer Chan; Lucy Lafay-Cousin; Sandra Dunn; Juliette Hukin; Chris Dunham; Katrin Scheinemann; Jean Michaud; Shayna Zelcer; David Ramsay; Jason Cain; Cameron Brennan; Mark M Souweidane; Chris Jones; C David Allis; Michael Brudno; Oren Becher; Cynthia Hawkins
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

6.  Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.

Authors:  Elaine Langenfeld; Malik Deen; Emmanuel Zachariah; John Langenfeld
Journal:  Mol Cancer       Date:  2013-10-26       Impact factor: 27.401

7.  Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.

Authors:  Dave J Augeri; Elaine Langenfeld; Monica Castle; John A Gilleran; John Langenfeld
Journal:  Mol Cancer       Date:  2016-04-06       Impact factor: 27.401

Review 8.  Glioma Stem Cells: Signaling, Microenvironment, and Therapy.

Authors:  Brandon D Liebelt; Takashi Shingu; Xin Zhou; Jiangong Ren; Seul A Shin; Jian Hu
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

9.  Bioinformatics analysis of the molecular mechanism of diffuse intrinsic pontine glioma.

Authors:  Lei Deng; Pengju Xiong; Yunhui Luo; Xiao Bu; Suokai Qian; Wuzhao Zhong
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

10.  Isolation and characterisation of CD9-positive pituitary adult stem/progenitor cells in rats.

Authors:  Kotaro Horiguchi; Ken Fujiwara; Saishu Yoshida; Takashi Nakakura; Ken Arae; Takehiro Tsukada; Rumi Hasegawa; Shu Takigami; Shunji Ohsako; Takashi Yashiro; Takako Kato; Yukio Kato
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.